What differentiates a buffy coat from PBMCs?

The definition of a buffy coat can vary depending on context. From a research laboratory perspective, a buffy coat is not the same as the buffy coat produced by a donor center or blood bank.

What differentiates a buffy coat from PBMCs?

Image Credit: BioIVT

The terms PBMCs (peripheral blood mononuclear cells) and buffy coat are often used interchangeably. However, the products differ in terms of cell subset composition. PBMCs refer to the isolated mononuclear fraction of white blood cells, whereas buffy coat usually describes the entire white blood cell layer after centrifugation.

A white blood cell “buffy coat” layer is separated when peripheral whole blood is centrifuged. The buffy coat layer consists of monocytes, lymphocytes, and granulocytes (as shown in Figure 1).

However, a clean PBMC layer is separated when whole blood is layered on a density gradient and centrifuged. The PBMC layer predominantly contains monocytes and lymphocytes, with low levels of granulocyte contamination due to differences in density (as shown in Figure 2).

What differentiates a buffy coat from PBMCs?

Image Credit: BioIVT

In a donor center or blood bank setting, a buffy coat is processed from a whole unit of blood, which is centrifuged in the original collection bag after donation. The centrifuged unit is then positioned on an expressor, which separates and transfers the buffy coat, plasma, and RBC (red blood cell) components into individual bags in a sterile, closed system (as shown in Figure 3).

What differentiates a buffy coat from PBMCs?

Image Credit: BioIVT

Buffy coat bags hold about 75-100 mL and resemble whole blood due to the low levels of RBCs. The bagged buffy coat comprises monocytes, lymphocytes, and some granulocytes.

The end application plays a crucial role in determining whether an isolated PBMC product or a buffy coat is appropriate. In most cases, researchers require isolated PBMCs, rather than buffy coats, due to the high purity of mononuclear cells (monocytes and lymphocytes).

BioIVT offers isolated PBMCs that have been quality control tested for both purity and viability to ensure high-quality cells to accelerate research. BioIVT supports its customers by providing a range of blood-derived immune cell products, offering both buffy coats isolated from whole blood units and isolated PBMCs.

About BioIVT

BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood, and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples.

Our Research Services team works collaboratively with clients to provide in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.

Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Feb 1, 2024 at 7:54 AM


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BioIVT. (2024, February 01). What differentiates a buffy coat from PBMCs?. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/whitepaper/20240201/What-Differentiates-a-Buffy-Coat-from-PBMCs.aspx.

  • MLA

    BioIVT. "What differentiates a buffy coat from PBMCs?". News-Medical. 18 April 2024. <https://www.news-medical.net/whitepaper/20240201/What-Differentiates-a-Buffy-Coat-from-PBMCs.aspx>.

  • Chicago

    BioIVT. "What differentiates a buffy coat from PBMCs?". News-Medical. https://www.news-medical.net/whitepaper/20240201/What-Differentiates-a-Buffy-Coat-from-PBMCs.aspx. (accessed April 18, 2024).

  • Harvard

    BioIVT. 2024. What differentiates a buffy coat from PBMCs?. News-Medical, viewed 18 April 2024, https://www.news-medical.net/whitepaper/20240201/What-Differentiates-a-Buffy-Coat-from-PBMCs.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.